FDA Gives Thumbs Up to Ovarian Cancer Drug Lynparza (Olaparib) In a clinical trial, AstraZeneca's Lynparza shrank and even removed ovarian tumor in women whose ovarian cancer is linked with genetic mutations. by Rhodi Lee
Healthy Living/Wellness FDA Approves Avastin Use for Ovarian Cancer Resistant to Platinum-containing Chemotherapy by Dianne Depra
Culture MTV Star Diem Brown Loses Battle With Cancer. Here's How She Won Hearts of 'The Challenge' Fans by Jan Dizon
Healthy Living/Wellness Endocyte Inc. to break into the big leagues with ovarian cancer drug Vynfinit; stock soars by Tabitha Laffernis
Healthy Living/Wellness Obesity bumps up likelihood of developing ovarian tumors by Tabitha Laffernis
Healthy Living/Wellness Early ovary removal by women with BRCA gene, may reduce long term breast and ovarian cancer risk by Rhodilee Jean Dolor